News Picture Generic

Chemspeed celebrates its 10th anniversary with Bayer HealthCare

January 7, 2012

Chemspeed recently celebrated 10 full operating years with Bayer HealthCare Pharmaceuticals (Bayer) in Berlin, Germany it runs five Chemspeed instruments in its laboratories. Building on the instrument reliability, Bayer is now moving to the next generation of Chemspeed’s equipment. Chemspeed was contacted by Bayer HealthCare Pharmaceuticals eleven years ago. The idea was to support the medicinal chemistry projects at Bayer using automated parallel synthesis which needed to be as flexible as possible. Chemspeed had developed the Chemspeed Synthesizer ASW2000 which was the first and only equipment which met Bayer’s needs at that time. Bayer HealthCare Pharmaceuticals bought the Synthesizer ASW2000 and later on, the Accelerator Synthesizer. Today, Bayer has five Synthesizers that are used on a regular basis. Each Synthesizer is programmed and configured identically, allowing easy exchange of program files or system accessories like reactors. The Chemspeed Synthesizer is the only fully integrated and automated workstation in the world for reaction preparation, synthesis (ambient pressure and pressure up to 100bar), work up, purification, analysis, output to storage vials / plates, incl. chemistry under inert gas (e.g. handling BuLi) and low-temperature (down to -70°C). Chemspeed’s instruments are still relevant today as the project orientation became even stronger recent the years. At Bayer, the project share for libraries nowadays is approaching 90%. Dr. Koppitz, Senior Scientist at Bayer HealthCare Pharmaceuticals said: “We like the platform approach which can be easily adapted to the different requirements at Bayer.

About Bayer HealthCare Pharmaceuticals Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, they focus their efforts where they can have the most impact. For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in healthcare. Additional information

Other Recent News

Discover more news articles you might be interested in

Read more about High-throughput solid microsampling through stochastic robotic automation
News Picture 1 1 V2
Featured
Jul
14

High-throughput solid microsampling through stochastic robotic automation

Solid sampling at the sub-milligram and milligram scale remains a major bottleneck for high-throughput chemistry or material sciences, as existing approaches rely on manual handling or slow deterministic microsampling that do not readily scale.

Here we present STORMS, an automated STOchastic Robotic MicroSampling system that enables fast, reliable and parallel sampling of solid materials at sub-milligram and milligram masses. 

Read more about Parameter efficient multi-model vision assistant for polymer solvation behaviour inference
News Picture 1 1 V2
Jun
30

Parameter efficient multi-model vision assistant for polymer solvation behaviour inference

Polymer–solvent systems exhibit complex solvation behaviours encompassing a diverse range of phenomena, including swelling, gelation, and dispersion. Accurate interpretation is often hindered by subjectivity, particularly in manual rapid screening assessments. While computer vision models hold significant promise to replace the reliance on human evaluation for inference, their adoption is limited by the lack of domain-specific datasets tailored, in our case, to polymer–solvent systems.

Read more about Continuous Flow Synthesis of Diglycolamides for Rare-Earth Elements Recovery: Algorithm-Accelerated Reaction Optimization Coupled with Automated Extraction Evaluation
News Picture 1 1 V2
Featured
Jun
23

Continuous Flow Synthesis of Diglycolamides for Rare-Earth Elements Recovery: Algorithm-Accelerated Reaction Optimization Coupled with Automated Extraction Evaluation

A first example of diglycolamide flow synthesis was developed, showcasing algorithm-accelerated reaction optimization and its potential to accelerate ligand discovery and enable autonomous, AIcontrolled manufacturing of critical materials. The increasing demand for manufacturing rare-earth elements (REEs) as critical materials has intensified research on sustainable synthesis of advanced extractants such as diglycolamides (DGAs).

© Chemspeed (part of Bruker) 2026